Overview

Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
A prospective, randomized controlled study to determine the efficacy of liposomal bupivacaine given by local injection at all the wound sites in patients undergoing urologic surgeries.
Phase:
Phase 4
Details
Lead Sponsor:
Loma Linda University
Treatments:
Bupivacaine